Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940$93 million in cash provides runway through expected clinical ...
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026 ...
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Neurocrine Biosciences initiates phase 1 study of NBIP-'2118, a corticotropin-releasing factor type 2 receptor agonist to treat obesity: San Diego Tuesday, May 5, 2026, 10:00 Hrs ...
Twelve North State high school students are finalists for Scholar-Athlete of the Year, with winners receiving scholarships.
Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. The GLP-1 ...
Phase 1 dose-escalation trial on track; preclinical combination data with anti-PD-1 antibody demonstrates potential for ...
BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as ' BrightGene Bio-Medical' or 'the Company') announced that its proprietary GLP-1 (glucagon-like peptide-1)/GIP ...
Biograph, the world’s most advanced preventive health and diagnostics clinic, today announced the evolution of its Executive ...
The News Press, in collaboration with Lee County high school principals and their staffs, are putting outstanding scholars in ...
One day, I got a call from Peter Bahouth, a former Greenpeace honcho whom Ted Turner had swiped to run his grant-making ...
They didn’t get the message. They won’t bow down. About 2,600 years ago, King Nebuchadnezzar erected a 90-foot-tall image of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results